Esketamine combined with remimazolam in painless gastroscopy in obese patients
Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 4
Abstract
"<b>Objective</b> To evaluate the effects and safety of esketamine combined with remimazolam in painless gastroscopy in obese patients. <b>Methods</b> A total of 138 obese patients who received elective painless gastroscopy at the Fourth Affiliated Hospital of Nanjing Medical University and Nanjing First Hospital from January to December 2022 were selected and randomly divided into group S (esketamine+remimazolam, n=69) and group C (propofol+remifentanil, n=69) by random number table method. The incidence of intraoperative hypoxemia, anesthesia induction time, test time, post-anesthesia care unit (PACU) monitoring time, and physician satisfaction were compared between two groups. The mean arterial pressure (MAP) and heart rate (HR) of two groups of patients before anesthesia (T<sub>0</sub>), at endoscopy insertion (T<sub>1</sub>), and at endoscopy retraction (T<sub>2</sub>) were recorded, and the incidence of adverse events were recorded. <b>Results</b> The incidence of hypoxemia in group S was significantly lower than that in group C ［34.78%(24/69) vs 56.52%(39/69)， χ<sup>2</sup>=6.571， P=0.010］. The induction time for anesthesia in group S was shorter than that in group C［(23.17±2.57) s vs (24.71±2.12) s， t=3.840， P＜0.01］. Compared with group C, the PACU monitoring time of group S was significantly shorter［(14.74±1.46) s vs (17.06±1.87) s, t=8.123， P＜0.01］, and the satisfaction of gastroenterologists［89.86%(62/69) vs 75.36%(52/69), χ<sup>2</sup>=5.044， P=0.025］ and satisfaction of anesthesiologists［92.75%(64/69) vs 71.01%(49/69), χ<sup>2</sup>=10.991， P=0.001］ was significantly higher. At T<sub>1</sub>, MAP in Group C decreased compared to group S, while HR increased compared to group S (P＜0.05). Nausea and vomiting occurred in 9 patients in group C and 5 patients in group S, and no other adverse event occurred. <b>Conclusion</b> Compared with propofol combined with remifentanil, remimazolam combined with eszketamine for painless gastroscopy in obese patients can reduce the incidence of hypoxemia and has higher safety."
Authors and Affiliations
WENG Liyang*, YANG Yuchun, MAO Gu, ZHANG Yong, XIE Li
Keywords
Related Articles
- EP ID EP734608
- DOI 10.13429/j.cnki.cjcr.2024.04.011
- Views 37
- Downloads 0
Research progress of regorafenib in the treatment of colorectal cancer
Colorectal cancer (CRC) is a common malignant tumor of digestive tract with an increasing incidence and mortality worldwide, and most patients have lost the opportunity of surgical treatment once diagnosed. With the cont...
Role and mechanism of mast cells in solid tumors
Mast cells are a type of innate immune cells, and have long been considered to be related to the pathogenesis of allergic and autoimmune diseases. However, in recent years, a number of studies have found that mast cells...
Correlation between triglyceride glucose index and atherosclerosis
"<b>Objective</b> To explore the correlation between triglyceride glucose (TyG) index and arteriosclerosis in natural population, and whether TyG index could be used as a predictor of poor prognosis of cardio-cerebrovasc...
Effects of unicondylar and total knee arthroplasty on knee osteoarthritis
<b>Objective</b> To compare the therapeutic effects of unicondylar knee arthroplasty (UKA) and total knee arthroplasty (TKA) on knee osteoarthritis (KOA) to provide references for the clinical selection of the best surg...
Research progress of lung cancer complicated with pulmonary embolism
Pulmonary embolism and deep venous thrombosis are collectively referred to as venous thromboembolism, while pulmonary embolism is generally caused by deep venous thrombosis, which has the characteristics of sudden and mo...